CCIA
NVAX icon

Campbell & Co Investment Adviser’s Novavax NVAX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-189,426
Closed -$1.19M – 1305
2025
Q2 		$1.19M Buy
+189,426
New +$1.25M 0.08% 425
2022
Q2 		– Sell
-8,132
Closed -$599K – 849
2022
Q1 		$599K Buy
+8,132
New +$725K 0.16% 205
2015
Q4 		– Sell
-666
Closed -$94K – 182
2015
Q3 		$94K Buy
+666
New +$149K 0.06% 307

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Campbell & Co Investment Adviser's NVAX Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Novavax (NVAX) in Q3 2025, closing a stake of 189,426 shares — an estimated $1.19M sold.

Campbell & Co Investment Adviser first reported a position in NVAX in Q3 2015 and held it in 3 quarters. The position peaked at $1.19M in Q2 2025. 250 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 189,426 Novavax shares in Q3 2025, an estimated $1.19M.
  • Campbell & Co Investment Adviser first reported a position in Novavax in Q3 2015 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Novavax position peaked at $1.19M in Q2 2025.
  • 250 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.